Bupropion as a modulator of drug activity
First Claim
1. A method, comprising administering for at least eight consecutive days a combination of dextromethorphan and bupropion to a human being, wherein the human being is an extensive metabolizer of dextromethorphan in need of treatment with dextromethorphan, wherein the combination is administered in a dosage form having properties effective for providing a Cmax of dextromethorphan on the eighth day of about 40 ng/mL to about 75 ng/mL, and wherein on the eighth day the combination is administered the Cmax of dextromethorphan is at least about 15 times the Cmax of dextromethorphan that would be achieved by administering the same amount of dextromethorphan without bupropion for eight consecutive days.
3 Assignments
0 Petitions
Accused Products
Abstract
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
-
Citations
30 Claims
- 1. A method, comprising administering for at least eight consecutive days a combination of dextromethorphan and bupropion to a human being, wherein the human being is an extensive metabolizer of dextromethorphan in need of treatment with dextromethorphan, wherein the combination is administered in a dosage form having properties effective for providing a Cmax of dextromethorphan on the eighth day of about 40 ng/mL to about 75 ng/mL, and wherein on the eighth day the combination is administered the Cmax of dextromethorphan is at least about 15 times the Cmax of dextromethorphan that would be achieved by administering the same amount of dextromethorphan without bupropion for eight consecutive days.
-
16. A method for treating a human being with dextromethorphan, comprising administering dextromethorphan and bupropion once or twice daily for at least eight consecutive days, wherein the human being is an extensive metabolizer of dextromethorphan in need of treatment with dextromethorphan, wherein dextromethorphan and bupropion are administered in amounts that result in an AUC0-12 of dextromethorphan on the eighth day that dextromethorphan and bupropion are administered that is about 400 ng·
- hr/mL to about 700 ng·
hr/mL, and wherein the AUC0-12 of dextromethorphan on the eighth day that dextromethorphan and bupropion are administered is at least about 20 times the AUC0-12 of dextromethorphan that would result from administering the same amount of dextromethorphan without bupropion. - View Dependent Claims (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
- hr/mL to about 700 ng·
Specification